Pluri Inc.

PLUR · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
367
SEC Filings

Business Summary

Pluri Inc. is a biotechnology company operating through its Israeli subsidiary Pluri Biotech Ltd. and related entities. The company develops cell-based technologies across regenerative medicine, immunotherapy, food technology, and agriculture technology (AgTech). Key products include PLX-PAD and PLX-R18 placenta-expanded cell therapies. Pluri also operates a Contract Development and Manufacturing Organization (CDMO) business leveraging its mass-scale, cost-effective cell expansion platform.

Next Earnings

Q2 FY2026 — expected 2026-09-08

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionPLURdiscussed_in_filing Cybersecurity
topic_mentionPLURdiscussed_in_filing Trusted Computing
topic_mentionPLURdiscussed_in_filing Blockchain & Crypto
topic_mentionPLURdiscussed_in_filing Supply Chain
topic_mentionPLURdiscussed_in_filing Regulation
topic_mentionPLURdiscussed_in_filing Healthcare & Bio
topic_mentionPLURdiscussed_in_filing Platform & Ecosystem
topic_mentionPLURdiscussed_in_filing Sovereign & Government
topic_mentionPLURdiscussed_in_filing Cybersecurity
topic_mentionPLURdiscussed_in_filing Trusted Computing
topic_mentionPLURdiscussed_in_filing Blockchain & Crypto
topic_mentionPLURdiscussed_in_filing Supply Chain
topic_mentionPLURdiscussed_in_filing Regulation
topic_mentionPLURdiscussed_in_filing Healthcare & Bio
topic_mentionPLURdiscussed_in_filing Platform & Ecosystem
topic_mentionPLURdiscussed_in_filing Sovereign & Government
topic_mentionPLURdiscussed_in_filing Cybersecurity
topic_mentionPLURdiscussed_in_filing Trusted Computing
topic_mentionPLURdiscussed_in_filing Blockchain & Crypto
topic_mentionPLURdiscussed_in_filing Supply Chain

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-09-172025-06-300001213900-25-088578EDGAR67K words
2024-09-182024-06-300001213900-24-079861EDGAR—
2023-09-122023-06-300001213900-23-076079EDGAR—
2022-09-212022-06-300001213900-22-057677EDGAR—
2021-09-132021-06-300001213900-21-047664EDGAR—
2020-09-102020-06-300001213900-20-026105EDGAR—
2019-09-122019-06-300001213900-19-017859EDGAR—
2018-09-122018-06-300001178913-18-002512EDGAR—
2017-09-072017-06-300001178913-17-002643EDGAR—
2016-09-072016-06-300001178913-16-006442EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-122025-12-310001213900-26-015550EDGAR20K words
2025-11-122025-09-300001213900-25-109174EDGAR—
2025-05-132025-03-310001213900-25-042637EDGAR—
2025-02-112024-12-310001213900-25-012189EDGAR—
2024-11-122024-09-300001213900-24-096763EDGAR—
2024-05-092024-03-310001213900-24-041274EDGAR—
2024-02-122023-12-310001213900-24-012549EDGAR—
2023-11-132023-09-300001213900-23-086065EDGAR—
2023-05-092023-03-310001213900-23-037682EDGAR—
2023-02-132022-12-310001213900-23-010734EDGAR—
2022-11-102022-09-300001213900-22-071138EDGAR—
2022-05-092022-03-310001213900-22-024864EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001213900-26-035110EDGAR18K words
2026-03-020001213900-26-022025EDGAR—
2026-01-220001213900-26-006685EDGAR—
2025-12-090001213900-25-119651EDGAR—
2025-10-160001213900-25-099632EDGAR—
2025-09-120001213900-25-087052EDGAR—
2025-09-110001213900-25-086670EDGAR—
2025-07-030001213900-25-061364EDGAR—
2025-05-270001213900-25-047562EDGAR—
2025-05-080001213900-25-040816EDGAR—

367 total filings indexed. 335 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Tags

regenerative-medicine immunotherapy food-technology-(foodtech) agriculture-technology-(agtech) cell-therapy-manufacturing-(cdmo)

Company Identity

CIK0001158780
TickerPLUR
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: be04a60474570dbe44fedd82e687a3d0381f2ef17072c1ad535276adacc0d55f
parent: e95440325842cd77a1173956e616f2158b6e1356e0a0cf738e7b5c9b7eeec91e
content hash: 8efb5ddbe3625e5babc5a62ec79753cf3e63e236ff3285ffb2bc5c2849220512
signed: 2026-04-13T04:46:56.123Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf